ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer
Clinical trial NCT00261313 · COMPLETED
Trial details
- NCT number
- NCT00261313
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2007-06-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.